1.

Record Nr.

UNINA990004909340403321

Autore

Fowler, Alastair

Titolo

Edmund Spenser, by Alastair Fowler / edited by Ian Scott-kilvert

Pubbl/distr/stampa

Harlow : Longman Group, c1977

ISBN

0-582-01271-6

Descrizione fisica

57 p. ; 22 cm

Collana

Writers and their work ; 258

Locazione

FLFBC

Collocazione

YR 2 258

Lingua di pubblicazione

Italiano

Formato

Materiale a stampa

Livello bibliografico

Monografia

2.

Record Nr.

UNINA9910437846003321

Titolo

Melt Extrusion : Materials, Technology and Drug Product Design / / edited by Michael A. Repka, Nigel Langley, James DiNunzio

Pubbl/distr/stampa

New York, NY : , : Springer New York : , : Imprint : Springer, , 2013

ISBN

1-4614-8432-4

Edizione

[1st ed. 2013.]

Descrizione fisica

1 online resource (472 p.)

Collana

AAPS Advances in the Pharmaceutical Sciences Series, , 2210-738X ; ; 9

Disciplina

615.19

Soggetti

Medicine - Research

Biology - Research

Pharmaceutical chemistry

Biomedical Research

Pharmaceutics

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.



Nota di contenuto

Melt Extrusion in Drug Delivery: Three Decades of Progress -- Twin Screw Extrusion for Pharmaceutical Processes -- Properties and Applications of Polyvinyllactam Polymers -- Properties and Applications of Hypromellose Acetate Succinate (HPMCAS) for Solubility Enhancement Using Melt Extrusion -- Cellulose Ethers for Extrusion Applications -- Properties and Applications of Polyethylene Oxide and Ethylcellulose for Tamper Resistance and Controlled Drug Delivery -- Formulation Development of Amorphous Solid Dispersions Prepared by Melt Extrusion -- Non-Sink In Vitro Dissolution Testing of Amorphous Solid Dispersions -- Manufacture of Pharmaceutically Relevant Materials by Mechanochemistry Using Twin Screw Extrusion -- Melt Extruded Controlled Release Dosage  Forms -- Excipient/API Melt Processing via Injection Molding -- Devices and Implants Prepared Using Hot Melt Extrusion -- Solid Lipid Extrusion -- Formulation, Bioavailability and Manufacturing Process Enhancement: Novel Applications of Melt Extrusion in Enabling Product Development -- Hot Melt Extrusion as a Continuous Pharmaceutical Manufacturing Process -- Hot-Melt Extrusion Process Design Using Process Analytical Technology -- Consistency of Pharmaceutical Products: An FDA Perspective on Hot-melt Extrusion Process -- Melt Extrusion: A Commercial Perception to Practicality -- Future Trends.

Sommario/riassunto

This inclusive text describes hot melt extrusion for pharmaceutical applications, focusing on the materials used for the preparation of solid dispersions, fundamentals for preparing such systems and novel applications using extrusion technology. Highlighting viewpoints from the academic, excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying hot melt extrusion for drug product development while also providing insight into the path forward for the technology in years to come.  Dr. Michael A. Repka is Chair and Professor of the Department of Pharmaceutics at The University of Mississippi, as well as Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via hot melt extrusion technology. Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks. Dr. Nigel Langley is currently Head of Marketing and Technical Sales at BASF Corporation where he is responsible for the promotion and technical support for BASF’s pharmaceutical excipients and APIs to the Pharmaceutical Industry in North America.  He has a strong interest in solubilization including hot melt extrusion. He received his Ph.D. in Liquid Crystals from Hull University, U.K., and an M.B.A. from Leeds University, U.K. Prior to joining BASF, he worked for Croda International in the U.K., Japan and the United States. Dr. James DiNunzio is currently an Associate Principal Scientist at Merck & Co., Inc. where he serves as a member of the Hot Melt Extrusion Technology Development Team.  He received his Ph.D. in Pharmacy from the University of Texas at Austin and holds M.S. and B.S. degrees inChemical Engineering from Columbia University and SUNY Buffalo, respectively.  His research interests include formulation design of amorphous dispersions, development of controlled release products using melt extrusion, continuous manufacturing and engineering of directly shaped drug products.